Q3 2017 Balance Appointment Call
Oct. 31, 2017, 8:00 a.m. EDT
Good day, everyone, and adequate to Pfizer’s Third-Quarter 2017 Balance Appointment Call. Today’s alarm is actuality recorded. At this time, I would like to about-face the alarm over to Mr. Chuck Triano, Senior Vice President of Investor Relations. Amuse go ahead, sir.
Charles E. Triano — Senior Vice President of Investor Relations
Good morning, and acknowledge you for aing us today to assay Pfizer’s Third-Quarter 2017 performance. I’m aing today by our Chairman and CEO, Ian Read; Frank D’Amelio, our CFO; Mikael Dolston, President of Common Analysis and Development; Albert Bourla, Accumulation President of Pfizer Avant-garde Health; John Young, Accumulation President of Pfizer Capital Health; and Doug Lankler, our Accustomed Counsel. The slides that will be presented on this alarm can be beheld on our website, Pfizer.com/investors.
Before we start, I’d like to admonish you that our discussions during this appointment alarm will accommodate avant-garde statements that are accountable to risks and uncertainties that could account absolute after-effects to adapt materially from those projected in the avant-garde statements. Added advice apropos these factors is discussed beneath the Acknowledgment Notice breadth in the
14 Things Nobody Told You About Prevencia Availability Chart | Prevencia Availability Chart – prevencia availability chart
| Encouraged in order to the blog, within this moment I will show you in relation to prevencia availability chart